Financials data is unavailable for this security.
View more
Year on year Merck & Co Inc 's net income fell -97.49% from 14.52bn to 365.00m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 16.78% to 17.27%.
Gross margin | 76.59% |
---|---|
Net profit margin | 19.25% |
Operating margin | 21.60% |
Return on assets | 10.85% |
---|---|
Return on equity | 28.33% |
Return on investment | 14.19% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Merck & Co Inc fell by 5.86bn. However, the company earned 13.01bn from its operations for a Cash Flow Margin of 21.64%. In addition the company used 14.08bn on investing activities and also paid 4.81bn in financing cash flows.
Cash flow per share | 6.49 |
---|---|
Price/Cash flow per share | 15.85 |
Book value per share | 17.58 |
---|---|
Tangible book value per share | 2.29 |
More ▼
Balance sheet in USDView more
Current ratio | 1.36 |
---|---|
Quick ratio | 1.15 |
Total debt/total equity | 0.8568 |
---|---|
Total debt/total capital | 0.4611 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 2.85% |
---|---|
Div growth rate (5 year) | 8.26% |
Payout ratio (TTM) | 64.59% |
EPS growth(5 years) | -43.23 |
---|---|
EPS (TTM) vs TTM 1 year ago | 164.22 |
More ▼